Adrenal disease

Improving diagnosis in primary aldosteronism using HISTALDO and nodule size metrics

Eur J EndocrinolPublished Prospective cohort study

Authors' conclusion

HISTALDO may over-report non-classical histology. Adding the B2 ratio improves diagnostic accuracy, distinguishing APA with background zona glomerulosa activity from true multinodular disease, facilitating patient management and follow-up.

Study context

Population
Patients with unilateral primary aldosteronism (PA) undergoing adrenalectomy (2017–2022), Karolinska University Hospital
Participants
75 patients
Exposure
HISTALDO vs HISTALDO with B2 ratio classification
Outcome
Histological classification (classical vs non-classical)
Methodological detailssingle-centre, standardized tissue sampling
  • Single-centre
  • Standardized tissue sampling

Main finding

As reported in the abstract

HISTALDO: classical cases
20
HISTALDO: non-classical cases
55
Median B2 ratio (non-classical)
9
Non-classical cases reclassified with B2 ratio cut-off ≥8.1
29/55
HISTALDO B2R: classical cases
49
HISTALDO B2R: non-classical cases
26

Observational data: associations, not effects.

Further findings

B2 ratio and complete clinical response (PASO criteria) · postoperative

Higher B2 ratios correlated with complete clinical response
P = 0.0038
B2 ratio as independent predictor of complete response (trend), OR
1.07, P = .058

B2 ratio and number of antihypertensive medications · postoperative

Higher B2 ratios correlated with fewer antihypertensive medications
R = −0.4, P = .0022

Original publication

Improving diagnosis in primary aldosteronism using HISTALDO and nodule size metrics. Eur J Endocrinol. Published 29 July 2025. doi:10.1093/ejendo/lvaf157

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.